Degradable poly-L-lysine-modified PLGA cell microcarriers with excellent antibacterial and osteogenic activity
- PMID: 31184220
- DOI: 10.1080/21691401.2019.1623230
Degradable poly-L-lysine-modified PLGA cell microcarriers with excellent antibacterial and osteogenic activity
Retraction in
-
Statement of Retraction.Artif Cells Nanomed Biotechnol. 2021 Dec;49(1):546. doi: 10.1080/21691401.2021.1951977. Artif Cells Nanomed Biotechnol. 2021. PMID: 34374611 No abstract available.
Abstract
The surface modification of polymeric materials has become critical for improving the bone repair capability of materials. In this study, we used a poly-L-lysine (PLL) coating method to prepare functional poly (lactic acid-glycolic acid) (PLGA) cell microcarriers, and bone morphogenetic protein 7 (BMP-7) and ponericin G1 were immobilized on the surface of microcarriers. The scanning electron microscopy (SEM), water contact angle measurement, and energy-dispersive X-ray spectroscopy (EDX) was used to analyse the surface morphology of PLL-modified PLGA microcarriers (PLL@PLGA) and their ability to promote mineralization. At the same time, the growth factor binding efficiency and antimicrobial activity of the microcarriers were studied. The effects of microcarriers on cell behaviors were evaluated by cultivating MC3T3-E1 cells on different microcarriers. The results showed that the hydrophilicity, protein adsorption, and mineralization induction capability of the microcarriers were significantly improved by PLL surface modification. The biological experiments revealed that BMP-7 and ponericin G1 immobilized-PLL modified microcarriers can effectively inhibit the proliferation of pathogenic microorganisms while enhancing the ability of the microcarriers to promote cell proliferation and osteogenesis differentiation. Therefore, we believe that PLL-modified PLGA cell microcarriers loaded with BMP-7 and ponericin G1 (PLL@PLGA/BMP-7/ponericin G1) have great potential in the field of bone repair.
Keywords: Poly-L-lysine surface modification Poly (lactic acid–glycolic acid) (PLGA cell microcarrier ponericin G1.
Similar articles
-
Enhancing Cell Proliferation and Osteogenic Differentiation of MC3T3-E1 Pre-osteoblasts by BMP-2 Delivery in Graphene Oxide-Incorporated PLGA/HA Biodegradable Microcarriers.Sci Rep. 2017 Oct 2;7(1):12549. doi: 10.1038/s41598-017-12935-x. Sci Rep. 2017. PMID: 28970533 Free PMC article.
-
Enhancement in sustained release of antimicrobial peptide and BMP-2 from degradable three dimensional-printed PLGA scaffold for bone regeneration.RSC Adv. 2019 Apr 4;9(19):10494-10507. doi: 10.1039/c8ra08788a. eCollection 2019 Apr 3. RSC Adv. 2019. PMID: 35515290 Free PMC article.
-
In vitro antibacterial activity and cytocompatibility of magnesium-incorporated poly(lactide-co-glycolic acid) scaffolds.Biomed Eng Online. 2020 Feb 18;19(1):12. doi: 10.1186/s12938-020-0755-x. Biomed Eng Online. 2020. PMID: 32070352 Free PMC article.
-
Triple PLGA/PCL Scaffold Modification Including Silver Impregnation, Collagen Coating, and Electrospinning Significantly Improve Biocompatibility, Antimicrobial, and Osteogenic Properties for Orofacial Tissue Regeneration.ACS Appl Mater Interfaces. 2019 Oct 16;11(41):37381-37396. doi: 10.1021/acsami.9b07053. Epub 2019 Oct 7. ACS Appl Mater Interfaces. 2019. PMID: 31517483 Free PMC article.
-
Surface Modification Progress for PLGA-Based Cell Scaffolds.Polymers (Basel). 2024 Jan 4;16(1):165. doi: 10.3390/polym16010165. Polymers (Basel). 2024. PMID: 38201830 Free PMC article. Review.
Cited by
-
Emerging Trends in Biodegradable Microcarriers for Therapeutic Applications.Polymers (Basel). 2023 Mar 16;15(6):1487. doi: 10.3390/polym15061487. Polymers (Basel). 2023. PMID: 36987266 Free PMC article. Review.
-
Nanobiotechnology with Therapeutically Relevant Macromolecules from Animal Venoms: Venoms, Toxins, and Antimicrobial Peptides.Pharmaceutics. 2022 Apr 19;14(5):891. doi: 10.3390/pharmaceutics14050891. Pharmaceutics. 2022. PMID: 35631477 Free PMC article. Review.
-
Advanced Surface Modification for 3D-Printed Titanium Alloy Implant Interface Functionalization.Front Bioeng Biotechnol. 2022 Mar 1;10:850110. doi: 10.3389/fbioe.2022.850110. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35299643 Free PMC article. Review.
-
Investigation of the structure-activity relationship in ponericin L1 from Neoponera goeldii.Pept Sci (Hoboken). 2020 May;112(3):e24162. doi: 10.1002/pep2.24162. Epub 2020 Mar 31. Pept Sci (Hoboken). 2020. PMID: 33937618 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
